This site is intended for healthcare professionals only
LoginRegister
HCBombay HC Notice to CDSCO on Denial of Phase I Trial for Indigenous Cancer Drug
Piramal Pharma gets 4 USFDA observations for Lexington facilityPiramal Pharma Turbhe facility gets USFDA EIR
cervical cancerUSFDA approves at home self-collection device for cervical cancer screening
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyOpen to expand US manufacturing as tariff threat looms: Dr Reddy's Labs
Himachal cracks down on pharma units, action taken against four facilitiesUSFDA successfully completes inspection at Solara Ambernath facility
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsIcotrokinra results show significant skin clearance in patients with difficult to treat scalp,...
Amid Global Headwinds, Brazil and Nigeria Fuel Indias Pharma Export GrowthDTAB Approves Notification System for Application of new drug, IND for clinical trial, BA-BE study
CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to QueriesCDSCO Revises Public Hearing Schedule
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer seeks Japenese nod for Aflibercept to treat macular edema following retinal vein occlusion
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealEli Lilly announces transitions in executive leadership
Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilitiesJohnson & Johnson Medtech, Qure.ai partner to enhance early detection of lung cancer in India
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkZealand Pharma announces closing of collaboration, license agreement with Roche
X